Pasar al contenido principal

CANALES IONICOS Y ENFERMEDAD VASCULAR: IDENTIFICANDO NUEVOS MECANISMOS PARA DESARROLLAR TERAPIAS DIRIGIDAS

PID2023-146750OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2023
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE VALLADOLID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A sex-dependent role of Kv1.3 channels from macrophages in metabolic syndrome

  • Peraza, Diego A.
  • Benito-Salamanca, Lucía
  • Moreno‐Estar, Sara
  • Alonso, Esperanza
  • López-López, José R.
  • Pérez-García, M. Teresa
  • Cidad, Pilar
[Introduction]: Coronary artery disease (CAD) is the foremost single cause of mortality and disability globally. Patients with type 2 diabetes (T2DM) have a higher incidence of CAD, and poorer prognosis. The low-grade inflammation associated to T2DM contributes to increased morbidity and worst outcomes after revascularization. Inflammatory signaling in the vasculature supports endothelial dysfunction, leukocyte infiltration, and macrophage activation to a metabolic disease (MMe) specific phenotype, which could contribute to the metabolic disorders and ascular damage in T2DM. We have previously found that Kv1.3 blockers inhibit the development of intimal hyperplasia, thereby preventing restenosis. This inhibition was enhanced in a mouse model of T2DM, where systemic Kv1.3 blockers administration also improve metabolic dysfunction by acting on unidentified cellular targets other than vascular smooth muscle. Here we characterize the MMe phenotype in our T2DM model with a focus on macrophage Kv1.3 channels, to explore their contribution to vascular disease and their potential role as targets to ameliorate T2DM vascular risk., [Methods and Results]: Male and female BPH mice fed on high-fat diet (HFD) develop metabolic syndrome (MetS) and T2DM. mRNA levels of several K+ channels (KV1.3, KCa3.1, Kir2.1) and macrophage markers (TNFα, NOS2, CD36) were analyzed. The MMe phenotype associated with increased CD36 expression. Channel-specific fingerprinting highlights a gender-specific increase of KV1.3 mRNA fold change in LPS stimulated macrophages from HFD compared to standard diet (SD). KV1.3 functional expression was also significantly increased after LPS stimulation in female HFD macrophages compared to SD. Functional studies showed that macrophage's KV1.3 channels of BPH female mice did not contribute to phagocytosis or metabolic profile but were relevant in cell migration rate., [Conclusion]: Altogether, our data suggest that by inhibiting macrophage infiltration, Kv1.3 blockers could contribute to disrupt the vicious cycle of inflammation and insulin resistance, offering a novel approach to prevent MetS, T2DM and its associated cardiovascular complications in females., This work was supported by grants PID2020-118517RB-I00 and PID2023-146750OB-I00 from the Spanish Agencia Estatal de Investigación (MICIU/AEI/10.13039/501100011033) and VA172P20 and VA186P24 from the Junta de Castilla y León (JCyL). DAP has a postdoctoral Juan de la Cierva training grant, FJC2021-046455-I, financed by the Spanish Government, MCIN/AEI/10.13039/501100011033, and by the European Union “NextGenerationEU/PRTR” and SME had a JCyL predoctoral contract., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Vascular Smooth Muscle Cell Migration and P70S6K: Key Players in Intimal Hyperplasia Development

  • Moreno‐Estar, Sara
  • Cidad, Pilar
  • Arévalo-Martínez, Marycarmen
  • Portillo, Ana M.
  • Sacristan‐Moraleda, Marcos
  • Alonso, Esperanza
  • López-López, José R.
[Background] Vascular smooth muscle cell (VSMC) recruitment and activation by vessel injury cause intimal hyperplasia (IH) and restenosis. Drug‐eluting stents releasing mTOR (mechanistic target of rapamycin) blockers (sirolimus, everolimus [EV]) improve surgery outcomes but exhibit nonspecific effects and poor efficacy in diseased vessels. Drug combinations targeting the multifactorial processes leading to IH could enhance efficacy and reduce toxicity. Our previous work showed that Kv1.3 channel blockers such as 5‐(4‐phenoxybutoxy)psoralen (PAP‐1) prevented IH. Since Kv1.3 signaling works through the MEK/ERK pathway, we hypothesize that PAP‐1 and EV combination could improve antirestenotic therapies., [Methods and Results] The effects of PAP‐1, EV, and their combination on IH development were studied in vivo using a carotid ligation mouse model and ex vivo in organ culture of human vessels. Individually, both drugs inhibited vessel remodeling, but, surprisingly, their combination canceled these inhibitory effects. In primary human VSMCs cultures, the drug combination abolished the inhibition of cell migration but not cell proliferation, which was even potentiated. We uncovered a crosstalk between mTOR and MEK/ERK pathways in VSMCs, centered on P70S6K activation. P70S6K phosphorylation levels correlated with IH development, even reproducing the differences in EV response between diabetic and nondiabetic samples., [Conclusions] VSMC migration, rather than proliferation, mirrors PAP‐1 and EV effects on IH development in vessels. Critically, we identify VSMC P70S6K phosphorylation as a surrogate marker for IH progression. The nonmonotonic responses of P70S6K activation to pathway blockers suggest the existence of a crosstalk element functioning as an exclusive NOR logic gate providing new insights for IH prevention strategies., This work was supported by grants PID2020‐118517RB‐I00 and PID2023‐146750OB‐I00 from the Spanish Agencia Estatal de Investigación (MICIU/AEI/https://doi.org/10.13039/501100011033) and VA172P20 and VA186P24 from the Junta de Castilla y León (JCyL). SME had a JCyL postdoctoral contract and MAM a postdoctoral Margarita Salas training grant from the Spanish Government., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Renal TRPM3 Channels Regulate Blood Pressure via Tubuloglomerular Feedback and Plasma Volume Control

  • Rojo-Mencía, Jorge
  • Alonso-Carbajo, Lucía
  • Arévalo-Martínez, Marycarmen
  • Benito-Salamanca, Lucía
  • Talavera, Karel
  • Pérez-García, M. Teresa
  • López-López, José R.
  • Cidad, Pilar
[Background] TRPM3 is a nonselective cation channel activated by heat, osmotic pressure, and neurosteroids. It is highly expressed in sensory neurons, where it integrates thermal, chemical, and inflammatory signals to modulate downstream responses, but is also present in the brain, kidney, and cardiovascular system. This distribution suggests a role in cardiovascular and renal regulation. We hypothesize that TRPM3 channels may play a role in blood pressure (BP) regulation via both vascular and renal mechanisms. Therefore, analysis of the vascular phenotype in Trpm3-KO mice can provide insights into the channel’s potential contribution to hypertension development., [Methods] BP was monitored noninvasively in conscious wild-type and Trpm3-KO mice under basal conditions and after oral losartan treatment or angiotensin II infusion via osmotic minipumps. TRPM3 expression in vessels and kidney structures was examined using immunofluorescence microscopy and RNAscope with specific cell markers. Ex vivo renal perfusion and pressure myography were used to evaluate vascular responses., [Results] Trpm3-KO mice showed a ≈5% BP reduction and resistance to angiotensin II-induced hypertension. Urine [Na⁺] was 35% to 50% higher, and plasma volume was 20% lower, suggesting a renal origin of the hypotension. TRPM3 was localized at the juxtaglomerular apparatus and distal nephron segments involved in plasma volume regulation. Trpm3-KO mice exhibited impaired tubuloglomerular feedback, reducing afferent arteriole constriction and NaCl reabsorption., [Conclusions] TRPM3 channels contribute to BP regulation by modulating kidney function. Blunted tubuloglomerular feedback in Trpm3-KO mice disrupts NaCl reabsorption, leading to hypovolemia and lower BP. Thus, renal TRPM3 channels may serve as promising targets for BP regulation., This work was supported by grants PID2020-118517RB-I00 and PID2023-146750OB-I00 from the Spanish Agencia Estatal de Investigación (MICIU/AEI/10.13039/501100011033), VA172P20 from the Junta de Castilla y León (JCyL) and G0C6815N from the Flemish Research Foundation (FWO to K. Talavera). J. Rojo-Mencia had a JCyL predoctoral contract and MAM a postdoctoral Margarita Salas training grant from the Spanish Government., Peer reviewed